Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Maprotiline and nortriptyline are both medications used to treat depression, but they belong to different classes. Maprotiline was a tetracyclic antidepressant, but is no longer available in the U.S. Nortriptyline, sold under the brand name Pamelor, is a tricyclic antidepressant (TCA). Nortriptyline is sometimes used off-label for nerve pain and migraine prevention, although it is not FDA-approved for these uses. Nortriptyline is available in both capsule and liquid forms, while maprotiline was only available in oral form before its discontinuation. Common side effects of nortriptyline include dry mouth, dizziness, and weight gain. Nortriptyline can cause withdrawal symptoms if stopped abruptly, and it has several drug interactions, including with sedatives and MAOIs.
Maprotiline
Nortriptyline (Pamelor)
Maprotiline
Nortriptyline (Pamelor)
Summary of Maprotiline vs. Pamelor
Summary for Tetracyclic antidepressant
Prescription only
Maprotiline is an antidepressant used to treat depression and anxiety associated with depression. It's no longer available in the United States because it was discontinued.
Summary for Tricyclic antidepressant
Prescription only
Nortriptyline (Pamelor) is a tricyclic antidepressant (TCA). It's approved to treat depression in adults. This medication is also often prescribed off-label to treat certain types of nerve pain. Nortriptyline (Pamelor) is available as a capsule and liquid that are taken by mouth. Side effects include dry mouth, dizziness, and possible weight gain. This medication is available under the brand name Pamelor and as a generic.